Document is current
Any future updates will be listed below
-
Authors
Kaur, Simranpreet
Sehgal, Anuj
Wu, Andy C.
Millard, Susan M.
Batoon, Lena
Sandrock, Cheyenne J.
Ferrari-Cestari, Michelle
Levesque, Jean-Pierre
Hume, David A.
Raggatt, Liza J.
Pettit, Allison R. https://orcid.org/0000-0003-4707-7892
-
Funding
Funding for this research was provided by:
Equity Trustees
National Health and Medical Research Council (APP1102964, APP1046590, APP1136130)
Australian Research Council, Future Fellowship (FT150100335)
The University of Queensland International Scholarship
- License Information
-
More Information
Article History
Received: 14 September 2020
Accepted: 11 November 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: All procedures complied with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes and were approved by The University of Queensland (UQ) Health Sciences Ethics Committee. All use of animals in this study was performed under Animal Welfare Assurance Number: A5092-01; AEC Approval Numbre MRI-UQ/TRI/165/16/NHMRC. Recombinant fusion protein work was carried out under authority of UQ Office of the Gene Technology Regulator (OGTR) under Accreditation Number: ACCR-030, Project Identifier IBC/1182/TRI/MRI.
: Not applicable.
: The authors declare no competing interests.
